[1] |
GUO Zhiyu, CAO Tianyu, WANG Weidong, GUO Xingxian, MA Wanqi, LU Yuanyuan, ZHAO Xiaodi, JI Gang.
Correlation between blood lipid levels and survival prognosis of gastric cancer patients under operation: A retrospective cohort study
[J]. Chinese Journal of Oncology Prevention and Treatment, 2024, 16(6): 687-693.
|
[2] |
PAN Hongxin, CUI Wangfei, LYU Licheng, WANG Xinzheng, CAO Ling, ZHANG Yongzhen.
Analysis of the incidence and mortality of malignant tumors in tumor registration areas of Shanxi Province,2020
[J]. Chinese Journal of Oncology Prevention and Treatment, 2024, 16(6): 700-706.
|
[3] |
DONG Junling, YANG Hui, LI Na.
Trend of the incidence of gastric cancer in China,1992—2021
[J]. Chinese Journal of Oncology Prevention and Treatment, 2024, 16(5): 593-597.
|
[4] |
SU Lili, LAN Zhenyu, LIN Huizhe, YAN Fangna, CHEN Weilian, LIN Wei.
Effects of sarcopenia on prognosis of prostate cancer treatment: a Meta-analysis
[J]. Chinese Journal of Oncology Prevention and Treatment, 2024, 16(4): 487-493.
|
[5] |
YAN Haiqing, LAI Qinqiao, WU Liucheng, WANG Ting'an, XIA Xiang, HUANG Mingwei, QIN Yuzhou.
Effects of SH3BGRL on proliferation and migration of gastric cancer cells
[J]. Chinese Journal of Oncology Prevention and Treatment, 2024, 16(3): 285-294.
|
[6] |
SUN Xiaoxia, WANG Yuping, SI Meili, ZHU Jing, ZHONG Mei.
Trends of incidence and mortality and the age-period-cohort of cervical cancer in China,1990—2019
[J]. Chinese Journal of Oncology Prevention and Treatment, 2024, 16(3): 317-320.
|
[7] |
QIN Liming, ZHOU Zihan, CAO Ji, LI Qiulin, YU Jiahua, RONG Minhua, ZHAO Libin, MAI Yuejiao, GE Lianying, QIN Yuzhou, YU Hongping.
Epidemiological characteristics and disease burden analysis of gastric cancer in Guangxi,2011—2018
[J]. Chinese Journal of Oncology Prevention and Treatment, 2024, 16(2): 172-178.
|
[8] |
WANG Juwei, WANG Jing, MA Lijun, LI Zan .
Trends in the incidence and mortality of liver cancer in China based on the JoinPoint regression model,2000—2019
[J]. Chinese Journal of Oncology Prevention and Treatment, 2024, 16(2): 180-185.
|
[9] |
MA Fuchao, LIU Aiquan, XIE Weishun, SHEN Yanhua, FENG Jie, JIANG Qi, GE Lianying.
Screening and diagnostic efficacy evaluation of risk miRNAs during the development of gastric cancer: a multicenter study
[J]. Chinese Journal of Oncology Prevention and Treatment, 2024, 16(2): 193-199.
|
[10] |
ZHOU Zihan, LI Qiulin, YU Jiahua, RONG Minhua, CAO Ji, GE Lianying, TANG Weizhong, YU Hongping.
Analysis of the epidemiological characteristics and disease burden of malignant tumors in Guangxi, 2019#br#
[J]. Chinese Journal of Oncology Prevention and Treatment, 2024, 16(1): 67-.
|
[11] |
QIU Haiping, XIE Xiaoping, CHEN Tianqing.
A trend analysis of the incidence and mortality of lung cancer and an age-period-cohort model in China,1990—2019
[J]. Chinese Journal of Oncology Prevention and Treatment, 2023, 15(5): 537-542.
|
[12] |
LI Qiulin, YU Jiahua, RONG Minhua, ZHOU Zihan, CAO Ji, GE Lianying, YU Hongping, LIU Liang .
Epidemiological characteristics and the trend of disease burden of leukemia in children aged 0-14 years in Guangxi cancer registry areas,2015-2019
[J]. Chinese Journal of Oncology Prevention and Treatment, 2023, 15(3): 304-310.
|
[13] |
ZHOU Zihan, LI Qiulin, YU Jiahua, RONG Minhua, LIAN Jiawei, MAI Yuejiao, CAO Ji, GE Lianying, TANG Weizhong, YU Hongping.
Analysis of the epidemiological characteristics of malignant tumors and disease burden in Guangxi,2018
[J]. Chinese Journal of Oncology Prevention and Treatment, 2023, 15(2): 181-199.
|
[14] |
WANG Xin, ZHANG Xiaopeng, LI Jiajia, SUN Feng, YANG Linsheng, ZHA Zhenqiu.
Analysis of the incidence trend of malignant tumors of digestive system in Hefei, 2011—2015
[J]. Chinese Journal of Oncology Prevention and Treatment, 2023, 15(1): 38-44.
|
[15] |
ZHANG Xu, HUA Jing, FAN Kangqiong, SU Liangping, WANG Dingbin.
Analysis of the incidence and mortality of malignant tumors in the cancer registration areas of Hainan,2017
[J]. Chinese Journal of Oncology Prevention and Treatment, 2023, 15(1): 45-51.
|